Microbot Medical MBOT
NASDAQ MBOT
$1.50 +0.01 (+0.67%)
At close: Aug 21, 2026 · 4:00 PM EDT

Microbot Medical (MBOT) Current Deferred Revenue (2010 - 2025)

Microbot Medical's (MBOT) quarterly Current Deferred Revenue came in at $93000.0 in Q4 2025, up 452.72% on a QoQ basis from $16826.0 in Q3 2016.

Microbot Medical (MBOT) Current Deferred Revenue (2010 - 2025) Analysis & Trends

Microbot Medical (MBOT) has 8 years of Current Deferred Revenue data on file, last reported at $93000.0 in Q4 2025.

  • Quarterly Current Deferred Revenue changed N/A year-over-year to $93000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $93000.0 (changed N/A YoY) and the FY2025 annual result came in at $93000.0, changed N/A from the prior year.
  • Current Deferred Revenue rose to $93000.0 in Q4 2025, from $16826.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $93000.0 in Q4 2025 to a low of $93000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Microbot Medical 101.07 Mn 101.07 Mn 2,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 93,000.00
Sep 30, 2016 16,826.00
Jun 30, 2016 16,826.00
Mar 31, 2016 141,344.00
Dec 31, 2015 132,338.00
Sep 30, 2015 123,333.00
Jun 30, 2015 16,826.00
Mar 31, 2015 16,826.00
Dec 31, 2014 16,826.00
Sep 30, 2014 27,524.00
Jun 30, 2014 44,758.00
Mar 31, 2014 61,202.00
Dec 31, 2013 34,366.00
Sep 30, 2013 67,588.00
Jun 30, 2013 23,597.00
Mar 31, 2013 48,595.00
Dec 31, 2012 74,426.00
Sep 30, 2012 55,955.00
Jun 30, 2012 651.00
Mar 31, 2012 39,371.00